Authors
Latest:
Synchronization of Treatment With Erythropoiesis-Stimulating Agents and ChemotherapyIn outpatient oncology clinics, erythropoiesis-stimulating agents and chemotherapy were found to be typically administered during the same visits, as opposed to requiring separate visits.
Latest:
Outcomes of a Specialty Pharmacy Program for Oral Oncology MedicationsOur research focuses on the clinical and economic outcomes of patients receiving care from a payer-designated specialty pharmacy program compared with regular retail pharmacies.
Latest:
Point-of-Care Testing Offers New OpportunitiesConsider these steps for pharmacists to further evolve their role as the pandemic continues to put pressure on the health care system.
Latest:
An Intermittent Reinforcement Platform to Increase Adherence to MedicationsAn automated reinforcement platform was shown to increase statin adherence by 34.6%.
Latest:
Specialty Pharmacy Takes Center Stage in Cancer CareThe oncology pharmaceutical market is rapidly growing and changing.
Latest:
Pharmacists Are Coming to the RescueAs Pharmacy Times® goes to press this month, there is a lot of encouraging news on the coronavirus 2019 (COVID-19) front.
Latest:
US Primary Care Providers' Use of Over-the-Counter Medications for Gastroesophageal Reflux Disease and Chronic ConstipationThe perception and utilization of OTC medications among primary care providers for gastroesophageal reflux disease and chronic constipation shows a need for improved patient education on these medications.
Latest:
Utilization Impacts of New Oral Substitutes for Parenteral Cancer-Related TherapiesExamination of changes in utilization, dose adequacy, and duration associated with market entry of the oral chelator deferasirox as a potential substitute for parenteral deferoxamine.
Latest:
COVID-19 and the Impact on Oral Oncolytics: A Specialty Pharmacy PerspectiveThe increasing prevalence of oral oncolytics use, further accelerated by COVID-19, heightens the need for strong patient-pharmacist treatment coordination.
Latest:
Hepatitis C Case Study at Prosperity Specialty PharmacyAdherence for targeted therapies is even more essential now than it ever has been. This case study of services offered at a specialty pharmacy illustrates the impact of hepatitis C patients.
Latest:
Outpatient Adherence to Risperidone Long-Acting Injection Following Discharge From a State Psychiatric HospitalAdherence to risperidone long-acting injection (RLAI) therapy in the outpatient setting was poor. Degree of discharge planning from inpatient hospitalization was not associated with RLAI adherence.
Latest:
Integrated Pharmacy Savings Programs: A New Approach to Improve Satisfaction While Closing the Gaps in Coverage and CareAs we shift the healthcare paradigm, new ways to lower costs and improve adherence are worth another look.
Latest:
Value-Based Insurance Design and Antidiabetic Medication AdherenceAmong the commercially insured, pharmacy benefits define the availability, accessibility, and cost of prescription drugs.
Latest:
Evaluation of Therapeutic Interchange From Donepezil to Galantamine Extended-ReleaseTherapeutic interchange from donepezil to galantamine extended-release: a 3-month analysis.
Latest:
App Offers Retinopathy Screening for Patients with DiabetesRetina Risk is a new app that patients can use to help screen for their risk of retinopathy.
Latest:
The Impact of Abuse Deterrent Technologies on Prescription Opioid TrendsThe authors examined trends in the utilization of prescription opioid medication following introduction of abuse deterrent technology for Oxycontin.
Latest:
Challenges for Launching Biosimilar ProductsThe ability of manufacturers to convey the efficacy and safety of a new biosimilar is crucial.
Latest:
New Antimicrobials Expand Treatment OptionsEravacycline, Omadacycline, Plazomicin, and a Rifamycin Add to the Armamentarium for Treating Resistant Infections
Latest:
Generics Outlook: Turning to Innovation After the Patent CliffAs 2018 signals the end of the patent cliff and branded generics face tougher competition from nonbranded manufacturers, companies are diversifying their portfolios and focusing on innovation to ensure long-term viability.
Latest:
Outpatient Cancer Center Cost Evaluation of Extended Beyond-Use Dating with a Closed-System Transfer DeviceThere is a constant balancing act for health care systems to provide the newest and most up-to-date care for patients while being financially responsible.
Latest:
The Expanding Role of New Medications in the Treatment of Type 2 Diabetes MellitusWe examined the prevalence of use and cost impact of DPP-4 inhibitors and GLP-1 receptor agonists in people with diabetes.
